Aarti Pharma Labs P/B Ratio
Aarti Pharma Labs (AARTIPHARM) P/B ratio is 3.18 (High), book value per share ₹442.22 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Aarti Pharma Labs share price screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
AARTIPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Aarti Pharma Labs price-to-book ratio interpretation, valuation status and historical context — current P/B 3.18 (High). View Aarti Pharma Labs 52-week for the annual high/low range and current price position.
- Stock appears overvalued with PB of 3.18, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 93.9% above historical average
- Trading at premium to sector average PB of -0.94
Aarti Pharma Labs P/B Ratio Historical Trend
AARTIPHARM annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with AARTIPHARM fair price to assess whether the stock is under or overvalued.
AARTIPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Aarti Pharma Labs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.7 | ₹442.22 | ₹752.40 | ₹1,990 | Moderate |
| 2024 | 1.76 | ₹390.44 | ₹686.25 | ₹1,757 | Moderate |
| 2023 | 1.46 | ₹346.44 | ₹504.45 | ₹1,559 | Moderate |
AARTIPHARM vs Healthcare Peers — P/B Ratio Comparison
Aarti Pharma Labs P/B 3.18 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |